This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 5, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Vanguard S&P SmallCap 600 ETF (VIOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOO
Should Vanguard S&P SmallCap 600 ETF (VIOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOO
Why Small-Cap ETFs Won in February & May See Success in March
by Sanghamitra Saha
The Russell 2000 has beaten its bigger peers in the past week.
ETFs to Play the Reopening Trade as Omicron Fear Subsides
by Sweta Jaiswal, FRM
The improved market sentiments have been leading to greater attention and confidence in reopening trades.
Why Reopening-Friendly ETFs Can be Bought on the Dip?
by Sanghamitra Saha
Omicron is believed to be less severe than Delta by some experts while President Biden is not planning to impose lockdown now. With economies and citizens having learnt to deal with COVID variants in the past two years, fresh global shutdown is less likely.
Are Small Caps the Best Bets for 2022? ETFs in Focus
by Sanghamitra Saha
Wall Street may be hovering around a record high level but small-caps offer dirt cheap valuation. There are several other factors that support the small-cap rally, going forward.
Should Vanguard S&P SmallCap 600 ETF (VIOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOO
ETFs to Play the Reopening Trade on Merck's Oral Antiviral Pill News
by Sweta Jaiswal, FRM
Let's take a look at ETFs that are well-poised to gain as the reopening of the U.S. economy may pick up further pace following Merck's announcement.
4 Small-Cap ETFs & Stocks to Explode Higher
by Sweta Killa
With renewed optimism over a sustained economic recovery and robust corporate earnings growth, the small-cap space is set to explode higher.
ETFs to Rise on Full FDA Approval for Pfizer COVID-19 Vaccine
by Sweta Jaiswal, FRM
Let's look at the ETFs that are well-poised to gain as Comirnaty's full FDA approval is likely to drive the vaccination rate.
Here's Why Small-Cap ETFs Are Sizzling With Opportunities
by Sweta Jaiswal, FRM
Considering the upbeat scenario around small-cap ETFs, let's glance through some funds that investors can bet on.
Tap the Current Market Momentum With These ETF Strategies
by Sweta Jaiswal, FRM
Here we discuss certain ETF strategies to help investors gain from optimism surrounding the recovering U.S. economy from the pandemic-led slump despite surging delta variant cases.
ETF Strategies to Cheer the Dovish Fed Minutes
by Sweta Jaiswal, FRM
Here we discuss certain ETF strategies to help investors gain from optimism surrounding the Fed's dovish stance amid recovering U.S. economy from the pandemic-led slump.
The Zacks Analyst Blog Highlights: XLI, VCR, KBWB, VIOO and SPY
by Zacks Equity Research
The Zacks Analyst Blog Highlights: XLI, VCR, KBWB, VIOO and SPY
5 ETFs That Make Attractive Bets for Q3
by Sweta Jaiswal, FRM
Let's take a look at five ETFs that can be good additions to the portfolio amid the rapidly recovering U.S. economy.
ETF Strategies to Play the Drop in New US COVID-19 Cases
by Sweta Jaiswal, FRM
Here we discuss some ETF strategies that investors can play amid the upbeat outlook for the U.S. market.
ETFs to Play Reopening Trade as New US COVID-19 Cases Drop
by Sweta Jaiswal, FRM
Here we highlight some ETFs that can make great picks to ride the optimism surrounding the reopening of the U.S. economy amid declining coronavirus cases.
ETFs to Play the Reopening US Economy Optimism
by Sweta Jaiswal, FRM
Here we highlight some ETFs that can make great picks to ride the optimism surrounding the reopening of the U.S. economy.
Cash in on the Reopening US Economy Optimism With These ETFs
by Sweta Jaiswal, FRM
Let's look at some ETFs that are well-poised to gain as the reopening of U.S. economy picks up pace.
Take a Look at These 5 ETFs to Ride the Market Bulls
by Sweta Jaiswal, FRM
It is being believed that the chances of another trench of coronavirus-aid package and improved coronavirus vaccine rollout are making a strong case in favor of faster U.S. economic recovery in 2021.
Buy 5 High-Beta ETFs Offering Value to Tap Santa Rally
by Sanghamitra Saha
Stimulus deal appears to set the stage for the Santa rally in 2020.
ETF Strategies to Gain From Vaccine Hopes & Biden's Transition
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from the upbeat coronavirus vaccine data amid the health crisis.
Small Caps at the Forefront of Market Rally: 5 ETF Winners
by Sweta Killa
While the rally has been broad-based across all the market caps, small-caps stocks, as indicated by the Russell 2000 Index, has been outperforming and is hitting new all-time highs.
Small-Cap and Energy: 2 ETFs to Watch for Outsized Volume
by Sweta Killa
VIOO and PXJ saw massive trading volumes yesterday.
Zacks Market Edge Highlights: MRK, ABBV, PXD, VBR and VIOO
by Zacks Equity Research
Zacks Market Edge Highlights: MRK, ABBV, PXD, VBR and VIOO